October 10, 2025Deleted Journal

COVID-19 Update: 2025-2026 Vaccine Formulations and Recommendations

View Full Paper

Ask AI

Bookmark

The FDA has licensed new formulations of mRNA COVID-19 vaccines for adults over 65 and high-risk youth.
New vaccines include Comirnaty by Pfizer and Spikevax by Moderna, targeting various age groups.
Emergency Use Authorization for the Pfizer vaccine in younger children has been withdrawn, showing evolving guidelines.
These updates emphasize the importance of vaccination amid ongoing COVID-19 concerns.

Discussion

No takes yet. Share an insight, caveat, or question.

FDA licensed mRNA vaccines by Pfizer and Moderna for high-risk adults, indicating their importance against severe COVID-19.

A 2025 study studied this question.

View Full Paper

Ask AI

Bookmark